Meta-analysis
Published: Jun 2016
ACE Report #9121
Ace Report Cover Metabolic Disorders

Network meta-analysis of anti-osteoporosis therapies for oral glucocorticoid users

Study Type:Meta-analysis/Systematic Review
OE Level Evidence:2
Journal Level of Evidence:N/A

Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis

Osteoporos Int. 2016 Jun;27(6):1989-98

Contributing Authors: JD Adachi MA Amiche JM Albaum M Tadrous P Pechlivanoglou LE Lévesque SM Cadarette

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Explore some of our unlocked reports below!

Zoledronic acid increases BMD and prevents fracture risks in women with osteoporosis
Effects of 2.5mg zoledronate are long-lasting and similar to 5mg dose in osteopenic women
Network meta-analysis of current drug options for the treatment of osteoporosis in men
Immediate effects on bone metabolism biomarkers noted with resistance training and walking
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.